Lisata Therapeutics, Inc. (FRA:8NE)

Germany flag Germany · Delayed Price · Currency is EUR
1.640
+0.010 (0.61%)
At close: Dec 19, 2025
-32.79%
Market Cap15.51M
Revenue (ttm)911.96K
Net Income (ttm)-15.55M
Shares Outn/a
EPS (ttm)-1.81
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3
Average Volume0
Open1.630
Previous Close1.630
Day's Range1.630 - 1.640
52-Week Range1.550 - 3.660
Betan/a
RSI44.57
Earnings DateFeb 27, 2026

About Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is hea... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 26
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NE
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.